Research suggests that certain gut microbiota, such as Lactobacillus reuteri, may play a role in protecting against various diseases and conditions, including renal injury and coronary heart disease. The gut microbiota is also being studied for its potential impact on cancer immunotherapy responses and its relationship to chronic kidney disease. The mechanisms by which gut microbiota influences these conditions, and potential therapeutic targets, are being explored in various studies.